NCT02428764 2024-12-10
Neoadjuvant Nimotuzumab Plus Gemcitabine and Carboplatin in Unresectable Stage III Squamous Cell Lung Carcinoma
Sun Yat-sen University
Phase 2 Withdrawn
Clinical Trials
12 trialsNCT02947386 2023-10-05
Nimotuzumab and Nivolumab in Treating Patients With Advanced Non-small Cell Lung Cancer
Roswell Park Cancer Institute
Phase 1 Completed
NCT03574402 2022-12-06
TRUMP
Guangdong Association of Clinical Trials
Phase 2 Unknown
NCT04833205 2021-04-20
Clinical Efficacy and Safety of EGFR-TKI Combined With Nimotuzumab in the Treatment of Leptomeningeal Metastases From Lung Cancer
Hebei Medical University
Phase 2 Unknown
NCT02577341 2021-02-11
Nimotuzumab Combined With Chemoradiotherapy for Unresectable Locally Advanced Squamous Cell Lung Cancer
Sun Yat-sen University
Phase 2 Completed
NCT01393080 2016-02-17
NSCLC
Tianjin Medical University Cancer Institute and Hospital
Phase NA Unknown
NCT00983047 2015-08-27
Nimotuzumab Plus Docetaxel in Chemotherapy-Refractory/Resistant Patients With Advanced Non-Small-Cell Lung Cancer
Biotech Pharmaceutical Co., Ltd.
Phase 2 Terminated
NCT00985998 2015-08-19
Nimotuzumab in Combination With Cisplatin and Docetaxel for Patients With Advanced Non-small Cell Lung Cancer
Biotech Pharmaceutical Co., Ltd.
Phase 1 Withdrawn
NCT01498562 2014-12-02
DATE
Yonsei University
Phase 2 Completed
NCT01861223 2014-02-25
Afatinib Plus Nimotuzumb for NSCLC
Samsung Medical Center
Phase 1/2 Unknown
NCT00369447 2011-07-01
A Study of Nimotuzumab in Combination With External Radiotherapy in Non-Small Cell Lung Cancer
YM BioSciences
Phase 1/2 Terminated
NCT00872482 2011-07-01
A Study of Nimotuzumab in Combination With Radiation Therapy in Patients With Brain Metastases
YM BioSciences
Phase 2 Terminated